Ashburton (Jersey)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-219,096
Closed -$13M 84
2020
Q1
$13M Hold
219,096
6.21% 8
2019
Q4
$16.3M Sell
219,096
-15,180
-6% -$1.07M 6.59% 8
2019
Q3
$14.8M Buy
234,276
+31,665
+16% +$1.88M 7.29% 7
2019
Q2
$11M Buy
202,611
+6,526
+3% +$351K 5.25% 11
2019
Q1
$10.6M Buy
196,085
+16,923
+9% +$1.04M 5.38% 10
2018
Q4
$11.7M Buy
179,162
+2,908
+2% +$217K 5.53% 11
2018
Q3
$13.9M Buy
176,254
+115,657
+191% +$8.27M 5.33% 11
2018
Q2
$3.9M Buy
60,597
+1,711
+3% +$113K 1.68% 12
2018
Q1
$3.66M Buy
58,886
+3,864
+7% +$277K 1.52% 13
2017
Q4
$3.99M Sell
55,022
-96,137
-64% -$6.99M 1.59% 12
2017
Q3
$12.3M Buy
151,159
+5,625
+4% +$445K 5.39% 10
2017
Q2
$11.7M Sell
145,534
-6,526
-4% -$515K 6.66% 10
2017
Q1
$11.9M Hold
152,060
5.67% 10
2016
Q4
$12M Buy
152,060
+10,258
+7% +$830K 5.16% 9
2016
Q3
$12.6M Sell
141,802
-2,237
-2% -$211K 5.76% 6
2016
Q2
$13.8M Sell
144,039
-13,961
-9% -$1.39M 5.73% 4
2016
Q1
$16.4M Buy
158,000
+6,903
+5% +$671K 5.74% 2
2015
Q4
$14.9M Buy
+151,097
New +$14.8M 3.96% 8

Other funds holding CVS

Ashburton (Jersey)'s CVS Position: Q2 2020 in Review

Ashburton (Jersey) sold out of CVS Health (CVS) in Q2 2020, closing a stake of 219,096 shares — an estimated $13M sold.

Ashburton (Jersey) first reported a position in CVS in Q4 2015 and held it in 18 quarters. The position peaked at $16.4M in Q1 2016. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Ashburton (Jersey) reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Ashburton (Jersey) sold 219,096 CVS Health shares in Q2 2020, an estimated $13M.
  • Ashburton (Jersey) first reported a position in CVS Health in Q4 2015 and held it in 18 quarters.
  • Ashburton (Jersey)'s CVS Health position peaked at $16.4M in Q1 2016.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Ashburton (Jersey)'s 13F filing for Q2 2020, filed 6 Aug 2020.